Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells

König B, Lahodny J. Translational Medicine Communications, 2022.

View the abstract on PubMed

Study type
Case series
People studied
6 people
Published
2022, Translational Medicine Communications
Identifiers
PMID 35880042, DOI 10.1186/s41231-022-00123-7
Group
Background science and mechanism studies

What the authors reported

In 6 patients given two 10-pass ozone high-dose therapy (OHT) sessions within a week, a laboratory bioenergetic health index in blood cells improved, driven mainly by increased mitochondrial reserve capacity.

What limits this result

Six patients, no control group; a laboratory biomarker rather than a symptom or clinical outcome, co-authored by the technique's own developer. The abstract does not state a specific cumulative ozone dose in micrograms.

How ozone acts on blood and cells, how blood filters work, the laboratory and device-development studies behind the EBOO circuit, and studies that measure markers in the blood rather than how patients fare. None of these shows whether EBO2 helps patients. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.

How the study was done

Design
Pilot study of six consecutive patients given preventive ozone high-dose therapy (OHT)
Setting
Private Department of Gynecology and General Medicine (Dr. Johann Lahodny), St. Pölten, Austria
Read from
Read from the full text of the paper. Read on September 28, 2026.

Sources: Full text on PubMed Central, Abstract on PubMed

Study arms

Each group as the paper describes it.
GroupParticipantsWhat they received
Six patients given preventive 10-pass OHT6OHT for preventive purposes, twice within one week

Source: Abstract on PubMed

Procedure as reported

Ozone concentration
70 μg/mLOxygen ozone gas mixture, 200 mL, is generated at an ozone concentration of 70 μg/mL
Blood volume
200 mL of patient’s blood withdrawn per pass200 mL of patient’s blood is withdrawn from a peripheral vein into a vacuum flask containing of 7500 units of heparin
Session length
Approximately one hour for one L1 (10 passes)
Sessions
2 OHT applications over a period of 1 week
Anticoagulant
7500 units of heparin (in the vacuum flask)

In the paper's own units, not converted.

Sources: Full text on PubMed Central, Abstract on PubMed

What it measured

Bioenergetic health index (BHI) in peripheral blood mononuclear cells
Improves significantly after just 2 OHT applications over a period of 1 week
Reserve capacity and maximum respiration of the mitochondria
Significant increase; the overall BHI improvement is based primarily on it
Non-mitochondrial oxygen consumption
Increased; the paper says this increase has a negative impact on the BHI value
BHI comparisons between the three sampling times (V, N, NN as defined in the Fig. 1 caption)
P-values: 0,045 (NN versus V); 0,198 (N versus V); 0,079 (N versus NN)

Sources: Abstract on PubMed, Full text on Europe PMC

Safety as reported

No adverse events are described for the six patients. The introduction says of major autohemotherapy generally that it has been carried out “without side-effects and with therapeutic results, albeit poorly documented”

Source: Full text on PubMed Central

Follow-up

About one week: blood taken before treatment, immediately after the first treatment, and after the second treatment one week laterDuring this pilot study the blood which was routinely taken before treatment, immediately after the first treatment, and after the second treatment one week later was used for analysis of mitochondrial functions as well.

Source: Full text on PubMed Central

Funding and conflicts

Competing interests: JL has pioneered the 10-pass OHT method but does not hold a patent on it; JL uses the method at his private clinic and is invited to lectures worldwide

Source: Full text on PubMed Central

Where we cite this study

All studies we track · How the studies compare